Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTFRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...
Roche wants to expand diabetes business, not sell it supriya kashyap kashyap2 Feb 2017 11:27 AM ISTRoche is looking to expand its $2 billion-per-year diabetes business, not sell it or spin it off.Diagnostics division head Roland Diggelmann dismissed...